IMVT Immunovant, Inc.
Healthcare$33.86+0.00%OpenMarket Cap: $6.95B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.16
P/S
0.00
EV/EBITDA
-11.59
DCF Value
$4.93
FCF Yield
-5.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-68.2%
ROA
-52.8%
ROIC
-62.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $-159.6M | $-147.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-532.9M | $-505.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-114.4M | $-110.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-131.8M | $-126.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-127.2M | $-120.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-113.8M | $-106.4M | $— | — |
| FY null | $0.00 | NaN% | $-438.2M | $-413.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-114.3M | $-111.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-115.7M | $-109.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-94.3M | $-87.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-80.9M | $-75.3M | $— | — |
| FY null | $0.00 | NaN% | $-270.2M | $-259.3M | $— | — |